– Interview with Jill Fuss, Ph.D., Research Scientist at Lawrence Berkeley National Laboratory

Previous articleSolvay Triumphs Over Gen-Probe in Race to Acquire Innogenetics with $316M Offer
Next articleScientists Decipher the Shape of Ebola Virus Protein Bound to Immune System Antibody